(Q36577487)

English

Prevention of further bone mass loss by nasal calcitonin in patients on long term glucocorticoid therapy for asthma: a two year follow up study

scientific article published on November 1994

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Prevention of further bone mass loss by nasal calcitonin in patients on long term glucocorticoid therapy for asthma: a two year follow up study (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1 reference

based on heuristic

inferred from title

author name string

Luengo M

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Pons F

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Martinez de Osaba MJ

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Picado C

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

1 November 1994

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

49

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

11

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1099-1102

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Pathogenesis and treatment of steroid osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=475269

9 September 2017

Toward a cure for osteoporosis: reversal of excessive bone fragility

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=475269

9 September 2017

Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=475269

9 September 2017

Glucocorticoids decrease vitamin D receptor number and gene expression in human osteosarcoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=475269

28 June 2018

Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)

1 reference

https://pubmed.ncbi.nlm.nih.gov/7831624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of steroid-induced osteopenia with calcitonin in corticosteroid-dependent asthma. A one-year follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/7831624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin

1 reference

https://pubmed.ncbi.nlm.nih.gov/7831624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate

1 reference

https://pubmed.ncbi.nlm.nih.gov/7831624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/THX.49.11.1099

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36577487&oldid=1638489595"